Dig Dis Sci:减肥手术后 30 天再入院: 原因、对结果的影响和预测因素分析

2022-03-30 MedSci原创 MedSci原创

减肥手术,又称肥胖症手术,指针对严重肥胖人类,以减肥为目的的一系列医疗治疗手段。美国通常通过植入设备控制胃容量,例如:胃束带、胃内水球,或者物理缩小胃容量,缩胃手术或者是缩短小肠,胃旁路手术等。

肥胖影响近 36% 的美国成年人,且其患病率正在增加。减肥手术 (BSx) 是肥胖的可用治疗方法之一,美国每年进行约 216,000 次手术,鉴于它是一种常见的手术方式,而且可能与围手术期风险相关,因此提高其安全性已成为国家卫生事业的优先关注点。防止再入院一直是减肥中心主要追求的目标之一,先前已经确定了包括减肥手术在内的外科手术再入院的原因和预测因素,但尚未研究再入院死亡率等,因此,本项研究旨在确定30天再入院率、与再入院相关的死亡率、确定再入院的 10 大原因。

 

研究人员对 BSx入院后30天内重新入院的全国再入院数据库进行了回顾性研究。主要观察结果是:30 天再入院率、死亡率、与医疗保健相关的资源利用和再入院的独立预测因素。比较的组别是指入院、再入院和未入院患者。

共有 161,141 名患者接受了 BSx。30天再入院率为3.3%。再次入院的主要原因是脱水、急性肾损伤、静脉血栓栓塞事件和败血症。 与未再次入院的患者相比,再次入院的患者更有可能发生休克(0.5% VS 0.1%;P  < 0.01),机械通气没有差异(1.9% VS 2.0%;P = 0.83)。再入院与较高的住院死亡率(1.5% VS 0.1%;P  < 0.01)和住院时间延长(4.6 VS 2.4 天;P < 0.01)。再入院的住院总经济负担为 2.34 亿美元,总费用为 5870 万美元。再入院的独立预测因素是:Charlson 合并症指数≥ 3、住院时间更长和急性肾损伤。医疗保险、私人保险、30-39 kg/m2和 40-44 kg/m2的 BMI 与较低的再入院几率相关。

图:减肥手术术后再入院率

本项研究初步证实BSx 后的再入院与较高的住院死亡率相关,并造成较高的医疗负担。研究人员确定了可以针对减少 BSx 后再次入院、医疗保健负担以及患者发病率和死亡率的风险因素。

原始出处:

Pedro Palacios Argueta. et al. Thirty-Day Readmission After Bariatric Surgery: Causes, Effects on Outcomes, and Predictors. Digestive Diseases and Sciences.2022.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2013828, encodeId=6292201382810, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Oct 26 05:03:37 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207442, encodeId=7164120e4429c, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ced6507769, createdName=ms1000001160662156, createdTime=Thu Mar 31 09:42:42 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264401, encodeId=4e401264401a1, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Tue Mar 29 11:03:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1245521, encodeId=f7ca124552120, content=什么时候有懒人用的减肥神药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sun Mar 27 23:03:37 CST 2022, time=2022-03-27, status=1, ipAttribution=)]
    2022-10-26 cmj8wellington
  2. [GetPortalCommentsPageByObjectIdResponse(id=2013828, encodeId=6292201382810, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Oct 26 05:03:37 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207442, encodeId=7164120e4429c, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ced6507769, createdName=ms1000001160662156, createdTime=Thu Mar 31 09:42:42 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264401, encodeId=4e401264401a1, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Tue Mar 29 11:03:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1245521, encodeId=f7ca124552120, content=什么时候有懒人用的减肥神药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sun Mar 27 23:03:37 CST 2022, time=2022-03-27, status=1, ipAttribution=)]
    2022-03-31 ms1000001160662156

    学到了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2013828, encodeId=6292201382810, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Oct 26 05:03:37 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207442, encodeId=7164120e4429c, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ced6507769, createdName=ms1000001160662156, createdTime=Thu Mar 31 09:42:42 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264401, encodeId=4e401264401a1, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Tue Mar 29 11:03:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1245521, encodeId=f7ca124552120, content=什么时候有懒人用的减肥神药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sun Mar 27 23:03:37 CST 2022, time=2022-03-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2013828, encodeId=6292201382810, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Oct 26 05:03:37 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207442, encodeId=7164120e4429c, content=学到了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6ced6507769, createdName=ms1000001160662156, createdTime=Thu Mar 31 09:42:42 CST 2022, time=2022-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264401, encodeId=4e401264401a1, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Tue Mar 29 11:03:37 CST 2022, time=2022-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1245521, encodeId=f7ca124552120, content=什么时候有懒人用的减肥神药?, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sun Mar 27 23:03:37 CST 2022, time=2022-03-27, status=1, ipAttribution=)]
    2022-03-27 CHANGE

    什么时候有懒人用的减肥神药?

    0

相关资讯

Lancet子刊:减肥手术后,严重胰岛素抵抗型糖尿病患者不论代谢还是肾脏都明显获益!

SIRD亚组的患者在代谢手术后有更好的结果,无论是2型糖尿病的缓解还是肾功能,都没有额外的手术风险。

Eur Heart J:减肥手术与心血管疾病

当前的系统评价和荟萃分析表明,减肥手术与降低全因死亡率和心血管死亡率有关,并且降低了肥胖患者的几种心血管疾病发病率。因此,这些患者应考虑进行减肥手术。

Ann Intern Med:肥胖症和高血压患者减肥手术的三年结果

减肥手术对肥胖症和高血压患者的中期影响仍不确定。为了确定Roux-en-Y胃绕道术(RYGB)与单纯药物治疗(MT)相比对血压(BP)的3年影响,研究人员进行了一项随机临床试验,结果发表于Ann In

Diabetes Care:减肥还要靠脑子!低卡路里饮食与胃旁路手术大脑激活状态居然不同!

肥胖症和2型糖尿病(T2DM)是我们这个时代最大的全球健康挑战之一。

Diabetes Care:肥胖和糖尿病患者减肥手术与癌症发病率之间的关联

这些结果表明减肥手术可以预防肥胖和糖尿病患者的癌症发生,并且糖尿病的持久缓解与癌症风险降低相关。

Diabetes Care:减肥手术将使死亡率减半,哪种手术更有利于糖尿病患者的心血管结局?

糖尿病(DM)被世界卫生组织(WHO)认为是四大非传染性疾病之一。